Physiologic disposition and metabolic fate of indomethacin analogs. I. 1-p-chlorobenzylidenyl-5-methoxy-2-methylindene-3-acetic acid.
D000085:Acetates / Q000097:blood / Q000378:metabolism / Q000652:urine; D000284:Administration, Oral; D000818:Animals; D001593:Benzyl Compounds / Q000097:blood / Q000378:metabolism / Q000652:urine; D001646:Bile / Q000032:analysis; D002247:Carbon Isotopes; D004285:Dogs; D005243:Feces / Q000032:analysis; D007192:Indenes / Q000097:blood / Q000378:metabolism* / Q000652:urine; D007213:Indomethacin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000652:urine; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D000085:Acetates; D001593:Benzyl Compounds; D002247:Carbon Isotopes; D007192:Indenes; D007213:Indomethacin